Skip to main content
. 2017 May 19;9(5):173. doi: 10.3390/toxins9050173
2-mAb 4LCA + 6A mAbs
3-mAb 4LCA + 6A + 3B3 mAbs
4-mAb 4LCA + 6A + 3B3 + CR2 mAbs
BoNT/A botulinum neurotoxin type A
CR1 complement receptor 1
CTCF corrected total cell fluorescence
FP fusion protein
GPA glycophorin A
HC BoNT heavy chain
HC50 a recombinant 50 KD amino-terminal domain of BoNT/A
HP heteropolymer
IL-10 interleukin-10
LC BoNT light chain
LD50 mouse 50% lethal dose
M1 classical macrophage polarization
M2 alternative macrophage polarization
mAb monoclonal antibody
MFI mean fluorescent intensity
NMJ neuromuscular junction
RI-BoNT/A recombinant inactive BoNT/A
RBC red blood cells
S.D. Standard Deviation
S.E.M. Standard Error of the Mean
TLR toll-like receptor
TNF-α tumor necrosis factor-α